Sivasubramanian Baskar

2.5k citations

58 papers · 2.0k indexed · h-index 23

Immunology top 2%
Oncology top 5%
Molecular Biology top 10%
Genetics top 2%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Suzanne Ostrand‐Rosenberg Christoph Rader N Nabavi Adrian Wiestner L H Glimcher Gordon J. Freeman L M Nadler Ka Yin Kwong
Topics: Chronic Lymphocytic Leukemia Research (20 papers)Immunotherapy and Immune Responses (15 papers)CAR-T cell therapy research (11 papers)
Cited by: Immunology Genetics Oncology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: United States Japan India

In The Last Decade

Sivasubramanian Baskar

57 papers receiving 2.0k citations

Peers

Countries citing papers authored by Sivasubramanian Baskar

Since Specialization

Citations

This map shows the geographic impact of Sivasubramanian Baskar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivasubramanian Baskar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivasubramanian Baskar more than expected).

Fields of papers citing papers by Sivasubramanian Baskar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivasubramanian Baskar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivasubramanian Baskar. The network helps show where Sivasubramanian Baskar may publish in the future.

Co-authorship network of co-authors of Sivasubramanian Baskar

This figure shows the co-authorship network connecting the top 25 collaborators of Sivasubramanian Baskar. A scholar is included among the top collaborators of Sivasubramanian Baskar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivasubramanian Baskar. Sivasubramanian Baskar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy 2023 ·Clinical Cancer Research ·(unknown),Jonathan Chen,Erika M. Gaglione,Chingiz Underbayev,Pamela L. Tuma,Xin Tian,Lita A. Freeman,Sivasubramanian Baskar,Pia Nierman,Susan Soto,(unknown),Inhye E. Ahn,Clare Sun,Elena Bibikova,Tanja Nicole Hartmann,(unknown),Adrian Wiestner	11
2	Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib 2021 ·Clinical Cancer Research ·Maria João Baptista,Sivasubramanian Baskar,Erika M. Gaglione,Keyvan Keyvanfar,Inhye E. Ahn,Adrian Wiestner,Clare Sun	8
3	Tumor Antigen ROR1 Targeted Delivery of MiR-29b in Chronic Lymphocytic Leukemia Induces Epigenetic Reprograming Resulting in Cell Cycle Arrest 2017 ·Blood ·Chi‐Ling Chiang,(unknown),Rajeswaran Mani,Frank Frissora,Zhiliang Xie,Xiaomeng Huang,Sivasubramanian Baskar,Christoph Rader,Mitch A. Phelps,Guido Marcucci,John C. Byrd,James L. Lee,Natarajan Muthusamy	2
4	Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia 2015 ·Clinical Cancer Research ·Pavlína Janovská,(unknown),Karla Plevová,(unknown),(unknown),Markéta Kaucká,Petra Ovesná,(unknown),Marek Borský,Olga Stehlíková,Yvona Brychtová,Michael Doubek,(unknown),Sivasubramanian Baskar,Alois Kozubı́k,Šárka Pospı́šilová,Šárka Pavlová,Vı́tězslav Bryja	52
5	ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo 2015 ·Experimental Hematology ·Rajeswaran Mani,Chi‐Ling Chiang,Frank Frissora,(unknown),Xiaokui Mo,Sivasubramanian Baskar,Christoph Rader,Rebecca B. Klisovic,Mitch A. Phelps,Ching-Shih Chen,Robert J. Lee,John C. Byrd,Robert A. Baiocchi,L. James Lee,Natarajan Muthusamy	18
6	Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies 2012 ·PLoS ONE ·Hema Dave,Miriam R. Anver,Donna Butcher,Patrick O. Brown,Javed Khan,Alan S. Wayne,Sivasubramanian Baskar,Christoph Rader	40
7	Targeting malignant B cells with an immunotoxin against ROR1 2012 ·mAbs ·Sivasubramanian Baskar,Adrian Wiestner,Wyndham H. Wilson,Ira Pastan,Christoph Rader	56
8	Antibody-based Therapeutics for the Treatment of Human B cell Malignancies 2012 ·Current Allergy and Asthma Reports ·Sivasubramanian Baskar,Natarajan Muthusamy	3
9	A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease 2011 ·Blood ·Davide Bagnara,Matthew Kaufman,Carlo Calissano,Sonia Marsilio,Piers Patten,Rita Simone,(unknown),Xiao‐Jie Yan,Steven L. Allen,Jonathan E. Kolitz,Sivasubramanian Baskar,Christoph Rader,Håkan Mellstedt,Hodjattallah Rabbani,Annette Lee,Peter K. Gregersen,R. Kanti,Nicholas Chiorazzi	145
10	Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies 2011 ·PLoS ONE ·Jiahui Yang,Sivasubramanian Baskar,Ka Yin Kwong,Michael G. Kennedy,Adrian Wiestner,Christoph Rader	80
11	164 INTRAPERITONEAL TRANSPLANTATION OF HEPATOCYTES EMBEDDED IN THERMOREVERSIBLE GELATION POLYMER (MEBIOL GEL) IN ACUTE LIVER FAILURE RAT MODEL 2008 ·Journal of Hepatology ·N. Parveen,Aleem Ahmed Khan,Sivasubramanian Baskar,(unknown),P. Ravindra Babu,(unknown),Hiroshi Yoshioka,(unknown),C M Habibullah	5
12	Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes 2004 ·Journal of Clinical Investigation ·Sivasubramanian Baskar,Carol B. Kobrin,Larry W. Kwak	8
13	Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes 2004 ·Journal of Clinical Investigation ·Sivasubramanian Baskar,Carol B. Kobrin,Larry W. Kwak	54
14	Grass Immunotherapy Induces Inhibition of Allergen-Specific Human Peripheral Blood Mononuclear Cell Proliferation 1997 ·International Archives of Allergy and Immunology ·Sivasubramanian Baskar,Robert G. Hamilton,Philip S. Norman,Aftab A. Ansari	14
15	Expression of MHC Class II and B7–1 and B7–2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells 1996 ·Tissue Antigens ·Suzanne Ostrand‐Rosenberg,Sivasubramanian Baskar,Noelle B. Patterson	35
16	Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules 1996 ·The Journal of Immunology ·Sivasubramanian Baskar,Virginia K. Clements,L H Glimcher,N Nabavi,Suzanne Ostrand‐Rosenberg	64
17	Tumor Cells Expressing Major Histocompatibility Complex Class II and B7 Activation Molecules Stimulate Potent Tumor-Specific Immunity 1993 ·Journal of Immunotherapy ·Sivasubramanian Baskar,Nasrin Nabavi,(unknown),Suzanne Ostrand‐Rosenberg	25
18	Invariant chain alters the malignant phenotype of MHC class II+ tumor cells 1992 ·The Journal of Immunology ·Virginia K. Clements,Sivasubramanian Baskar,Todd D. Armstrong,Suzanne Ostrand‐Rosenberg	56
19	The presentation of l-tyrosine-azobenzenearsonate by different mouse Ia molecules uses a common agretope 1990 ·Molecular Immunology ·Sivasubramanian Baskar,Geoffrey H. Sunshine,Sidney Leskowitz	3
20	Fish Oil and Tocopherol-Induced Changes in Natural Killer Cell-Mediated Cytotoxicity and PGE2 Synthesis in Young and Old Mice 1988 ·Journal of Nutrition ·Simin Nikbin Meydani,Ganesa Yogeeswaran,(unknown),Sivasubramanian Baskar,Mohsen Meydani	91

About Sivasubramanian Baskar

Sivasubramanian Baskar is a scholar working on Genetics, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (20 papers), Immunotherapy and Immune Responses (15 papers) and CAR-T cell therapy research (11 papers). The work is most often cited by research in Immunology (1.1k citations), Genetics (432 citations) and Oncology (822 citations). Sivasubramanian Baskar has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Suzanne Ostrand‐Rosenberg, Christoph Rader, N Nabavi, Adrian Wiestner, L H Glimcher, Gordon J. Freeman, L M Nadler, Ka Yin Kwong, Larry W. Kwak and Russel Jones. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact